Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
16.60
-0.30 (-1.78%)
At close: Jun 27, 2025, 4:00 PM
18.21
+1.61 (9.70%)
After-hours: Jun 27, 2025, 5:17 PM EDT
Crescent Biopharma Employees
The last reported number of employees for Crescent Biopharma was 4.
Employees
4
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
248.23M
No historical employees data available.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CBIO News
- 11 days ago - Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million - GlobeNewsWire
- 22 days ago - GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals - Business Wire
- 4 weeks ago - Crescent Biopharma to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC - Business Wire
- 2 months ago - Crescent Biopharma Appoints David Lubner to Board of Directors - GlobeNewsWire
- 3 months ago - Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics - GlobeNewsWire
- 4 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - PRNewsWire
- 4 months ago - Crescent Biopharma to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire